Beijing Strong BiotechnologiesInc Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 3/6

Beijing Strong BiotechnologiesInc yıllık ortalama 17.5% oranında kazançlarını artırırken, Biotechs sektöründe kazançlar growing at 5.9% annual. Gelirler growing yılda ortalama 16.5% oranında artmaktadır. Beijing Strong BiotechnologiesInc'in özkaynak karlılığı 13.3% ve net marjı 30.1%'dir.

Anahtar bilgiler

17.5%

Kazanç büyüme oranı

14.6%

EPS büyüme oranı

Biotechs Sektör Büyümesi	11.3%
Gelir büyüme oranı	16.5%
Özkaynak getirisi	13.3%
Net Marj	30.1%
Son Kazanç Güncellemesi	30 Sep 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

Beijing Strong BiotechnologiesInc nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

XSEC:300406 Gelir, gider ve kazançlar (CNY Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri	Ar-Ge Giderleri
30 Sep 24	1,745	526	489	182
30 Jun 24	1,747	533	477	175
31 Mar 24	1,762	533	501	170
31 Dec 23	1,742	524	499	163
30 Sep 23	1,622	491	466	142
30 Jun 23	1,615	468	493	147
31 Mar 23	1,512	402	475	142
31 Dec 22	1,511	389	475	137
30 Sep 22	1,504	364	480	145
30 Jun 22	1,504	347	486	136
31 Mar 22	1,598	392	485	133
01 Jan 22	1,599	406	463	127
30 Sep 21	1,539	335	488	111
30 Jun 21	1,391	299	408	100
31 Mar 21	1,109	212	321	88
31 Dec 20	848	112	272	79
30 Sep 20	797	202	177	77
30 Jun 20	752	234	137	72
31 Mar 20	781	284	137	69
31 Dec 19	841	332	136	70
30 Sep 19	813	324	131	66
30 Jun 19	787	318	132	65
31 Mar 19	783	303	132	63
31 Dec 18	774	301	131	61
30 Sep 18	755	285	133	61
30 Jun 18	748	279	104	84
31 Mar 18	718	280	109	69
31 Dec 17	694	273	121	54
30 Sep 17	657	266	129	37
30 Jun 17	660	259	161	0
31 Mar 17	658	259	160	0
31 Dec 16	667	272	150	0
30 Sep 16	646	266	142	0
30 Jun 16	595	259	134	0
31 Mar 16	590	255	126	0
31 Dec 15	566	245	124	0
30 Sep 15	548	222	126	0
30 Jun 15	543	218	127	0
31 Mar 15	524	218	120	0
31 Dec 14	508	211	119	0
30 Sep 14	480	205	107	0
31 Dec 13	445	181	91	0

Kaliteli Kazançlar: 300406 yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: 300406 'nin mevcut net kar marjları (30.1%) geçen yılın (30.3%) değerinden daha düşüktür.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 300406 şirketinin kazancı son 5 yılda yılda 17.5% oranında arttı.

Büyüme Hızlandırma: 300406 'un son bir yıldaki kazanç büyümesi ( 7.1% ) 5 yıllık ortalamasının ( 17.5% /yıl) altındadır.

Kazançlar vs. Sektör: 300406 geçen yılki kazanç büyümesi ( 7.1% ) Biotechs sektörünün 0.08% değerini aştı.

Özkaynak Getirisi

Yüksek ROE: 300406 'nin Özsermaye Getirisi ( 13.3% ) düşük olarak değerlendiriliyor.

Beijing Strong BiotechnologiesInc Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 3/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

Third quarter 2024 earnings released: EPS: CN¥0.20 (vs CN¥0.22 in 3Q 2023)

Beijing Strong Biotechnologies,Inc. to Report Q3, 2024 Results on Oct 25, 2024

Second quarter 2024 earnings released: EPS: CN¥0.22 (vs CN¥0.22 in 2Q 2023)

Beijing Strong Biotechnologies,Inc. to Report First Half, 2024 Results on Aug 23, 2024

First quarter 2024 earnings released: EPS: CN¥0.21 (vs CN¥0.19 in 1Q 2023)

Full year 2023 earnings released: EPS: CN¥0.90 (vs CN¥0.67 in FY 2022)

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.20 (vs CN¥0.22 in 3Q 2023)

Investor sentiment deteriorates as stock falls 16%

Beijing Strong Biotechnologies,Inc. to Report Q3, 2024 Results on Oct 25, 2024

Investor sentiment improves as stock rises 18%

Second quarter 2024 earnings released: EPS: CN¥0.22 (vs CN¥0.22 in 2Q 2023)

Beijing Strong Biotechnologies,Inc. to Report First Half, 2024 Results on Aug 23, 2024

First quarter 2024 earnings released: EPS: CN¥0.21 (vs CN¥0.19 in 1Q 2023)

Upcoming dividend of CN¥0.20 per share

Beijing Strong Biotechnologies,Inc. Announces Final Cash Dividend (Tax Included) (A Shares) for 2023, Payable on 07 May 2024

Full year 2023 earnings released: EPS: CN¥0.90 (vs CN¥0.67 in FY 2022)

Beijing Strong Biotechnologies,Inc., Annual General Meeting, Apr 22, 2024

Investor sentiment improves as stock rises 15%

New minor risk - Share price stability

Beijing Strong Biotechnologies,Inc. to Report Fiscal Year 2023 Results on Mar 30, 2024

Third quarter 2023 earnings released: EPS: CN¥0.22 (vs CN¥0.18 in 3Q 2022)

Beijing Strong Biotechnologies,Inc. to Report Q3, 2023 Results on Oct 25, 2023

Beijing Strong Biotechnologies,Inc. Approves Executive Appointments

Insufficient new directors

Second quarter 2023 earnings released: EPS: CN¥0.22 (vs CN¥0.11 in 2Q 2022)

New minor risk - Dividend sustainability

Beijing Strong Biotechnologies, Inc. (SZSE:300406) announces an Equity Buyback for CNY 80 million worth of its shares.

Beijing Strong Biotechnologies, Inc. to Report First Half, 2023 Results on Aug 10, 2023

Beijing Strong Biotechnologies, Inc. Announces Dividend on Share A for 2022, Payable on May 22, 2023

Full year 2022 earnings released: EPS: CN¥0.67 (vs CN¥0.69 in FY 2021)

Now 21% undervalued

Third quarter 2022 earnings released: EPS: CN¥0.18 (vs CN¥0.15 in 3Q 2021)

Beijing Strong Biotechnologies, Inc. (SZSE:300406) signed an Equity Transfer Agreement to acquire an additional 4.45% stake in Fuzhou Maixin Biotech. Co., Ltd. from Xinyu Yuanlang Management Consulting Partnership (Limited Partnership) for approximately CNY 130 million.

Second quarter 2022 earnings released: EPS: CN¥0.11 (vs CN¥0.19 in 2Q 2021)

Beijing Strong Biotechnologies, Inc. Announces Final Dividend on A Shares for the Year 2021, Payable on 27 May 2022

Beijing Strong Biotechnologies, Inc. Approves Cash Dividend for 2021

Beijing Strong Biotechnologies, Inc. Announces Final Cash Dividend Proposal for 2021

Full year 2021 earnings released: EPS: CN¥0.69 (vs CN¥0.21 in FY 2020)

Beijing Strong Biotechnologies, Inc. (SZSE:300406) entered into an agreement to acquire 75% stake in Wuhan Healcare Pharmaceuticals Technology Development Co., Ltd. from Xia Zhihui and Wang Ying for CNY 4 million.

Investor sentiment improved over the past week

Beijing Strong Biotechnologies, Inc. (SZSE:300406) announces an Equity Buyback for CNY 100 million worth of its shares.

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.15 (vs CN¥0.10 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.19 (vs CN¥0.039 in 2Q 2020)

Beijing Strong Biotechnologies, Inc. Announces Final Cash Dividend for 2020, Payable on 27 May 2021

Full year 2020 earnings released: EPS CN¥0.21 (vs CN¥0.66 in FY 2019)

Full year 2020 earnings released: EPS CN¥0.21 (vs CN¥0.66 in FY 2019)

New 90-day low: CN¥20.29

Beijing Strong Biotechnologies, Inc. to Report Fiscal Year 2020 Results on Mar 26, 2021

New 90-day high: CN¥23.45

Third quarter earnings released

New 90-day low - CN¥19.38

First half earnings released

Beijing Strong Biotechnologies, Inc. to Report First Half, 2020 Results on Aug 28, 2020

Gelir ve Gider Dağılımı

Kazanç ve Gelir Geçmişi

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Özkaynak Getirisi

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin